Skip to main content

Table 1 SPIRIT figure—study schedule

From: Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

Back to article page

Trials

ISSN: 1745-6215